Trial intelligence / Profile preview

Metformin (Pars Mino vs. Apotex) in Type 2 Diabetes

NCT01228240Phase 4Completed

Sponsor
Zanjan University of Medical Sciences
Start
Dec 2008
Primary completion
Jul 2009
Modality
Small Molecules
01

Overview

A Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Zanjan University of Medical Sciences. Started Dec 2008; status: completed.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01228240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01228240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call